Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02764593
Title Chemotherapy +/- Nivolumab in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors RTOG Foundation, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Institute Palo Alto California 94304 United States Details
University of Florida Cancer Center at Orlando Health Orlando Florida 32806 United States Details
Emory University/Winship Cancer Institute Atlanta Georgia 30322 United States Details
University of Louisville Louisville Kentucky 40202 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
UPMC - Shadyside Hospital Pittsburgh Pennsylvania 15232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Inova Fairfax Hospital Falls Church Virginia 22042 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field